Background: Determining whether observed differences in health care can be called disparities requires persistence of differences after adjustment for relevant patient, provider, and health system factors. We examined whether providing dual-energy x-ray absorptiometry (DXA) test results directly to patients might reduce or eliminate racial differences in osteoporosis-related health care.
T wo million osteoporotic fractures occur each year in the United States as a result of low bone mineral density and pose a major public health problem. 1 Of these, 310,000 are hip fractures. 2, 3 Hip fractures often occur in older women who have osteoporosis (diagnosed or not) and who fall. 4, 5 Although white women have higher rates of hip fracture, black women have poorer outcomes including higher morbidity and mortality. [6] [7] [8] The primary preventive strategy for reducing fractures in the United States is screening for osteoporosis using dual-energy x-ray absorptiometry (DXA). 9 There are substantial racial differences in DXA screening and osteoporosis diagnosis and treatment rates. 6 For example, Curtis and colleagues report that among traditional Medicare beneficiaries, 33% of white versus 5% of black women had undergone osteoporosis screening. *Patients with osteoporosis (t score of femoral neck, hip, or spine r À2.5 or fracture risk assessment tool Z20%), or with a self-reported history of low-impact fracture, or with osteopenia (t score between À 1.0 and À2.5 at the femoral neck, hips, or lumbar spine) and a 10-year probability of a major osteoporosis-related fracture Z20% who are on osteoporosis pharmacotherapy or patients who do not have one of the above and are not on osteoporosis pharmacotherapy. 14 DXA indicates dual-energy x-ray absorptiometry. Cheng et al 10 reported that among traditional Medicare beneficiaries with fractures, osteoporosis was diagnosed nearly twice-as-often for white women compared with black women across all age groups. Hamrick et al reported that while 80% of white women received pharmacotherapy after osteoporosis diagnoses, only 68% of black women did. 11 What is not clear is whether these racial differences constitute disparities. In a groundbreaking 2003 US Institute of Medicine (IOM) report, Smedley et al defined racial disparities as "racial or ethnic differences in the quality of health care that are not due to access-related factors or clinical needs, preferences, and appropriateness of intervention." 12 That is, racial differences may be due to patient, provider, and/or institutional factors, and only constitute disparities if they exist after adjustment for these factors. Patient factors include the social determinants of health and health behaviors, provider factors include practice patterns and explicit and implicit biases, and institutional factors include access to and the organization of health care. The dearth of detailed information about these patient, provider, and institutional factors in administrative claims and medical records hinder efforts to determine if racial differences are true disparities.
We used data from the Patient Activation after DXA Report Notification (PAADRN) randomized controlled trial (RCT) 13, 14 to investigate and differentiate racial differences and disparities in bone health care among white and black women. PAADRN data are well suited to this task for 2 reasons. First, PAADRN's intervention focused on engaging patients in their bone health self-care, which has been shown in prior studies to be lower for blacks than for whites. 15 Second, PAADRN collected an extensive battery of data about numerous aspects of bone health knowledge, self-efficacy, and behaviors. 16 Accordingly, we use the PAADRN data on white and black women to explore these issues. Building on the recommendations of the IOM report, 12 we estimate 4 multivariable models for each of the 7 bone health measures. Through successive models, we provide insight into whether racial disparities in bone health can be explained by differences in patient and provider level factors.
METHODS

Design and Sample
PAADRN was a pragmatic RCT whose design has been detailed elsewhere. 17, 18 PAADRN enrolled 7749 patients presenting for DXA between February 2012 and August 2014 at the University of Iowa (UI), the University of Alabama at Birmingham (UAB), and Kaiser Permanente of Georgia (KPGA). Exclusion criteria were: (1) age 50 years and below; (2) prisoners or patients with overt cognitive disability; (3) patients who did not speak or read English; and (4) patients who were deaf or lacked access to a telephone. Baseline phone or face-to-face interviews occurred up to 28 days before or 3 days after their baseline DXA, with follow-up telephone interviews occurring at 12 weeks and 52 weeks post-DXA. Because this Brief Report focuses on racial differences and disparities, the sample excludes all patients from UI (where there were not enough black patients for analytic purposes) and all men from UAB and KPGA (because of the uncertainty about DXA screening in men). 9 Institutional Review Boards at UI, UAB, and KPGA approved the study protocol. Our full protocol is available at https://clinicaltrials.gov/ct2/show/NCT01507662.
Intervention
Intervention patients were notified of their DXA results via a tailored letter accompanied by an educational 
Outcomes
We examine 7 outcomes related to bone health at 12 weeks and 52 weeks post-DXA (Table 1 ). Measures included: (1) whether the patient correctly identified their baseline DXA results; (2) whether the patient was on guideline-concordant osteoporosis pharmacotherapy; (3) osteoporosis-related satisfaction; (4) osteoporosis knowledge; (5 and 6) osteoporosis self-efficacy for exercise and self-efficacy for diet; and (7) patient activation. All but the guideline-concordant care measure are based directly on scales of known reliability and validity, or to a shortened form (patient activation) of such a scale. Receipt of guideline-concordant pharmacotherapy occurred when patients reported taking osteoporosis pharmacotherapy when indicated, or when patients reported not taking osteoporosis pharmacotherapy when it was not indicated by their DXA results and other patient considerations according to National Osteoporosis Foundation (NOF) guidelines.
Covariates
Covariates included patient, provider, and institutional characteristics ( Table 2 ) important for differentiating racial differences and disparities according to the IOM framework. 12 Patient characteristics included sociodemographics (age, sex, race, and education), comorbidities, health habits (smoking, drinking, and exercise), self-reported health, prior bone health, health literacy and numeracy, and study DXA results. Provider characteristics included sex and specialty. Institutional characteristics were limited to DXA site.
Data Analyses
Baseline characteristics of white and black women are compared using bivariable methods. Linear mixed effects models are used to estimate 4 multivariable models for the 7 bone health measures (after standardizing the nonbinary measures). The first model contains only race as a covariate. The second model adjusts for patient, provider, and center factors. The third model further adjusts for receipt (or not) of the mailed letter intervention. The fourth model includes the interaction of the DXA centers with the intervention and is estimated to test for potential heterogeneity of treatment effects based on the site characteristics, including uniform employer-based insurance and practice protocols at KPGA versus UAB. In sensitivity analyses we restricted the sample to women 65 years old and above for whom osteoporosis treatment guidelines are most clearly applicable, and we used inverse probability of treatment weighting to adjust for the higher attrition rates among black women. Bonferroni adjustments are used to correct for multiplicity. All P-values are 2-tailed, with those r0.025 deemed statistically significant. All statistical analyses were performed using SAS 9.4 (SAS Inc., Cary, NC). Table 2 reveals significant (all P < 0.001) baseline differences between the 3484 white and 1041 black women in most domains including age, education, comorbidity, health habits, self-reported health, health literacy, DXA results, and provider characteristics. Black women are disadvantaged for many of these measures. Table 2 also reveals significant unadjusted differences between black and white women at 12 weeks and 52 weeks post-DXA on the osteoporosis health measures. Black women are less likely to correctly identify their DXA results and have less osteoporosis-related knowledge than white women (P < 0.001). At the same time, black women are more likely to be on guideline-concordant pharmacotherapy and are more satisfied with their care (P < 0.001). Table 3 contains the multivariable results for the osteoporosis health measures at 12 weeks post-DXA. Even after full adjustment (model 3), black women were less likely to correctly identify their DXA results (b = À 0.150, P < 0.001) and had lower osteoporosis-related knowledge (b = À 0.473, P < 0.001) than white women, suggesting health disparities. Table 3 also reveals a suppressed disparity (ie, a disparity that was only observed after adjustment for the covariates) and 2 suppressed advantages (ie, advantages that were only observed after adjustment for the covariates) for black women. The suppressed disparity is that before covariate adjustment, black women are more likely to be on guideline-concordant pharmacotherapy (model 1, b = 0.144, P < 0.001). After adjusting for the covariates (especially their DXA results); however, black women are less likely than white women to be on guideline-concordant pharmacotherapy (model 3, b = À 0.073, P < 0.001). The 2 suppressed advantages for black women reveal their greater self-efficacy for exercise (model 3, b = 0.166, P < 0.001) and their greater patient activation (model 3, b = 0.114, P = 0.012) after adjustment for the covariates, whereas the unadjusted analyses (model 1) revealed no such advantages. Table 4 contains the multivariable results for the osteoporosis health measures at 52 weeks post-DXA. Because these are consistent with those reported in Table 3 , they are not discussed here. The sensitivity analyses (all model 4 s in Tables 3 and 4 ) revealed no heterogeneity of treatment effects for the intervention across the 2 DXA centers (all P > 0.025). The sensitivity analyses restricting our analysis to women age 65 years old and above and those using inverse probability of treatment weighting to adjust for differential attrition were consistent with those shown in Tables 3 and 4 (available on request).
RESULTS
DISCUSSION
The IOM defines racial disparities as "racial or ethnic differences in the quality of health care that are not due to Model 1 includes race only (black vs. white). Model 2 includes race and covariates measured at baseline. Model 3 includes race, intervention, plus covariates measured at baseline. Model 4 includes race, intervention, interaction between intervention and site (KP vs. UAB), plus covariates measured at baseline. Baseline covariates include, site (KP vs. UAB), age (continuous), education, comorbidity (chronic obstructive pulmonary disease, depression and breast cancer), self-assessed health status (using self-reported health status, continuous), heath habits (current smoker, former smoker, and drinker), bone health (history of DXA, history of fracture and history of osteoporosis treatment), health literacy (continuous), health numeracy (continuous), study DXA, fracture risk, sex of provider, physician, and provider specialty.
CI indicates confidence interval; DXA, dual-energy x-ray absorptiometry; KP; Kaiser Permanente; UAB, University of Alabama at Birmingham. 12 This definition implies that before a difference can be called a disparity adjustment for patient, provider, and health system factors that are difficult to measure must take place.
In an analysis of white and black women from the PAADRN study we found that a subtle and nuanced story becomes visible after adjustment. For example, without adjustment black women were less likely to correctly recall their DXA result, and this difference persisted after adjustment fulfilling the IOM definition of a disparity. Alternatively, without adjustment black women appeared more likely to receive guideline-concordant therapy, but after adjustment black women were actually less likely to receive guideline-concordant therapy, which we have labeled as a suppressed disparity. Finally, black and white women had similar levels of patient activation in the unadjusted analyses, but after adjustment black women actually were more activated than white women, which we have labeled as a suppressed advantage. It is important to note that these suppressed disparities and advantages were seen only after adjustment for critical clinical details-in this case, the baseline DXA results.
We are unaware of any prior studies that have evaluated the impact of educational interventions on racial differences in osteoporosis. More broadly there are relatively few RCTs assessing the impact of educational interventions on racial differences outside of osteoporosis, though a number are currently underway. 14, 21 Tully et al reported that a pilot trial of patient empowerment improved blood pressure control among black intervention and usual care patients. 22 Thomas et al 23 found that an educational video reduced white-black differences in willingness to receive an implantable cardiac defibrillator.
A number of our other findings warrant brief elaboration. Both this analysis and related publications provide evidence that our mailed DXA result letter had similar effects in blacks and whites. 18, 24 This finding is important and suggests that despite critical differences in education, health literacy and numeracy, and baseline health status, well-crafted interventions targeting patients can provide similar benefits to both whites and blacks.
It is important to discuss future directions. The rise in patient advocacy, in patients being active partners in their own medical care, and in shared decision making makes it incumbent on the health care system to find ways to communicate results to diverse patient populations. Our tailored letters are a start, but future research needs to explore communication involving different diagnostic tests and using newer communication modalities (eg, patient portals and text messaging with embedded YouTube links). 13, 25 Our study has 3 limitations. The first is whether these results can be applied to newer communication modalities. The second is our focus only on white and black women at just 2 health systems. Finally, despite our extensive data collection we were unable to capture certain factors that are likely important in explaining racial differences, such as access to care (eg, travel distance), provider attitudes and biases, and institutional policies.
In conclusion, using data from the PAADRN study we found that certain unadjusted differences in bone health care between white and black women seem to be true disparities.
After careful risk adjustment, we also identified suppressed disparities and suppressed advantages that were not apparent in our unadjusted analyses. These results highlight the importance of carefully planning protocols for patient provider, and institutional data collection and subsequent statistical analyses when attempting to differentiate racial differences from racial disparities.
